Infectious complications in adult acute lymphoblastic leukemia (ALL): Experience at one single center

Leukemia and Lymphoma

Volumn 45, Issue 8, 2004, Pages 1617-1621

  Offidani, M ^a   Corvatta, L ^a   Malerba, L ^a   Marconi, M ^a   Leoni, P ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

ALL; Infection; Risk factors

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; GLUCOCORTICOID; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; PENICILLIN G; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER CENTER; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; EXPERIENCE; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NEUTROPENIA; OPPORTUNISTIC INFECTION; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INCIDENCE; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; METHYLPREDNISOLONE; MIDDLE AGED; NEUTROPENIA; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 3042777509     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190410001683660     Document Type: Article

References (17)

1. Viscoli, C. (2002) "Management of infection in cancer patients: studies of the EORTC International Antimicrobial Therapy Group (IATG)", European Journal of Cancer, 38, S82-S87.
2. Elting, L.S., Rubenstein, E.B., Rolston, K.V.I., et al. (1997) "Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials", Clinical Infectious Diseases, 25, 247-259.
3. Talcott, J.A., Siegel, R.D., Finberg, R., et al. (1992) "Risk assessment in cancer patients with fever and neutropenia: a rospective, two-center validation of a prediction rule", Journal of Clinical Oncology, 10, 316-322.
4. Klastersky, J., Paesamans, M., Rubenstein, E.B., et al. (2000) "The Multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients", Journal of Clinical Oncology, 18, 3038-3051.
5. Kern, W.V., Cometta, A., de Bock, R., et al. (1999) "Oral versus intravenous empiric therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy", New England Journal of Medicine, 341, 312-318.
6. Freifeld, A., Marchigiani, D., Walsh, T., et al. (1999) "A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy", New England Journal of Medicine, 341, 305-311.
7. Marchetti, O. and Calandra, T. (2002) "Infections in neutropenic cancer patients", The Lancet, 359, 723-724.
8. Ascioglu, S., Rex, J.H., de Pauw, B., et al. (2002) "Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hemopoietic stem cell transplants: an international consensus", Clinical Infectious Diseases, 34, 7-14.
9. Annino, L., Vegna, M.L., Camera, A, et al. (2002) "Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study", Blood, 99, 863-871.
10. Mandelli, M.F., Annino, L., Vegna, M.L., et al. (2001) Interim analysis of the GIMEMA ALL 0496 trial for adult acute lymphoblastic leukemia (ALL). In program and abstract, 6th Annual Meeting of the European Haematology Association. Abstract 692a.
11. Offidani, M., Corvatta, L., Centurioni, R., et al. (2003) "High dose daunorubicin as liposomal compound (Daunoxome) in elderly patients with acute lymphoblastic leukemia", The Hematology Journal, 4, 47-53.
12. Kantarjian, H.M., O'Brian, S., Smith, T.L., et al. (2000) "Results of treatment with Hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukaemia", Journal of Clinical Oncology, 3, 547-561.
13. Hallbook, H., Simonsson, B., Ahlgren, T., et al. (2002) "High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia", British Journal of Haematology, 118, 748-754.
14. Wisplinghoff, H., Seifert, H., Wenzel, R.P., et al. (2003) "Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States", Clinical Infectious Diseases, 36, 1103-1110.
15. Offidani, M., Corvatta, L., Olivieri, A., et al. (1999) "Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF", Bone Alarrow Transplantation, 24, 1079-1087.
16. Zervos, M.J., Hershberger, E., Nicolau, D.P., et al. (2003) "Relationship between fluoroquinolones use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000", Clinical Infectious Diseases, 37, 1643-1648.
17. Garcia-Suarez, J., Krsnik, I., Reyes, E., et al. (2003) "Elderly haematological patients with chemotherapy-induced febrile neutropenia have similar rates of infection and outcome to younger adults: a prospective study of risk-adapted therapy", British Journal of Haematology, 120, 209-216.